Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Tubilux Pharma Spa
FDA Inspection
•Tubilux Pharma Spa•April 6, 2018

Tubilux Pharma Spa – FDA Inspection, Apr 6, 2018

Record Details

This FDA Inspection record concerns Tubilux Pharma Spa, with an inspection on April 6, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Tubilux Pharma Spa
Inspection Date
April 6, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • David J. Gomes (Issuing Officer)
  • Joey V. Quitania (FDA Associated Person)
View Company Profile

ID · 6c2d27fc-317a-46ad-85a4-fd3fed10264b

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1047718
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

3
  1. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  2. 21 CFR 211.160(b)Scientifically sound laboratory controls
  3. 21 CFR 211.166(a)Lack of written stability program

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Tubilux Pharma Spa

3
DateClassificationOfficeProject area
June 14, 2024VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 10, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 9, 2016OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Tubilux Pharma Spa
  • FDA Inspection 1263915 - 2024-06-14
  • FDA Inspection 1115090 - 2019-12-10
  • FDA Inspection 998341 - 2016-12-09

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Tubilux Pharma Spa
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.